Andrew Liveris Lauds New Obama Focus On Economy


U.S. President Barack Obama's renewed focus on economic and regulatory issues shows a willingness to work with corporate America, the head of Dow Chemical said.
"The country's jobless recovery is not a good thing," Chief Executive Andrew Liveris said on Monday. "How can we make this a recovery that builds the new future? I think science-based regulations in our world are the only way forward."
Liveris has repeatedly made the case for a U.S.-based manufacturing renaissance, saying that the U.S. government and the private sector must work together to spur job growth.
Obama recently laid out his plan for an updated regulatory system in an opinion piece published in The Wall Street Journal. He is expected to further expound on the topic in his State of the Union speech before a joint session of Congress on Tuesday night.
"The president's op-ed was really progressive," said Liveris, who recently wrote the book "Make it in America: The Case for Reinventing the Economy," to outline his economic views. "A real blank-sheet-of-paper look at regulations across all industries is overdue. The president and his team are showing a great willingness to listen."
Liveris spoke at a news conference in Detroit where Midland, Mich.-based Dow Chemical announced a $10 million partnership with The Nature Conservancy.
Company
The Dow Chemical Company100 Larkin Center
48674 Midland
most read

Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.

VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Valerie Diele-Braun Leaves IMCD
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.

Novo Nordisk's CEO Lars Fruergaard Jørgensen Steps Down
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.

Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.